SCHEMBL7224938

SCHEMBL7224938

CCCCOC(=O)C(C)C(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
ATM Q13315 1/20 0.50
HCAR2 Q8TDS4 3/20 0.48
TSHR P16473 4/20 0.47
HPGD P15428 2/20 0.47
NAAA Q02083 1/20 0.43
MAPT P10636 2/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
EPHX1 P07099 1/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 1/20 0.40
ESR1 P03372 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17403977 1.00 ALDH1A1 (0.54) ALDH1A1ATMHCAR2TSHRHPGD
SCHEMBL7224840 0.93 NAAA (0.52) ALDH1A1ATMHCAR2TSHRNAAA
SCHEMBL7222882 0.91 NAAA (0.55) ALDH1A1HCAR2TSHRNAAAEPHX1
SCHEMBL7223840 0.91 NAAA (0.55) ALDH1A1HCAR2TSHRNAAAEPHX1
SCHEMBL27932851 0.91 NAAA (0.55) ALDH1A1HCAR2TSHRNAAAEPHX1
SCHEMBL12109582 0.91 NAAA (0.55) ALDH1A1HCAR2TSHRNAAAEPHX1
SCHEMBL7217000 0.91 NAAA (0.55) ALDH1A1HCAR2TSHRNAAAEPHX1
SCHEMBL7223295 0.91 NAAA (0.55) ALDH1A1HCAR2TSHRNAAAEPHX1
SCHEMBL7219188 0.91 NAAA (0.55) ALDH1A1HCAR2TSHRNAAAEPHX1
SCHEMBL7218987 0.91 NAAA (0.55) ALDH1A1HCAR2TSHRNAAAEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119655345-A Coffee replica made from a single component 航行食品股份有限公司 2025-03-21 CN claimed
CN-118510501-A Formulations and methods for treating climacteric symptoms 金卓拉公司 2024-08-16 CN claimed
CN-104918599-A Compositions for reducing TRPA1 and TRPV1 sensation PROCTER & GAMBLE 2015-09-16 CN claimed
CN-103319521-A Cyclic siloxane compositions for the release of active ingredients GEN ELECTRIC 2013-09-25 CN claimed
CN-118510501-A Formulations and methods for treating climacteric symptoms 金卓拉公司 2024-08-16 CN disclosed
CN-109952360-A Quantum dot dispersion liquid, self-luminous photosensitive polymer combination, the colour filter and image display device manufactured using it 东友精细化工有限公司 2019-06-28 CN disclosed
CN-109810589-A Light converts resin combination, light conversion layer folds substrate and image display device 东友精细化工有限公司 2019-05-28 CN disclosed
CN-108473484-A Compounds useful as TRPM8 modulators 赛诺米克斯公司 2018-08-31 CN disclosed
CN-104617260-B Method for improving durability of lithium-ion power battery, and lithium-ion power battery 潘珊 2017-01-11 CN disclosed
US-20160376234-A1 COLORING CURABLE RESIN COMPOSITION, CURED FILM, COLOR FILTER, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, IMAGE DISPLAY DEVICE, COMPOUND, AND CATION FUJIFILM CORPORATION (JP) 2016-12-29 US disclosed
CN-104918599-A Compositions for reducing TRPA1 and TRPV1 sensation PROCTER & GAMBLE 2015-09-16 CN disclosed
CN-102647921-A High acid beverage products and methods to extend probiotic stability TROPICANA PROD INC 2012-08-22 CN disclosed
CN-100522127-C Perfume composition KAO CORP (JP) 2009-08-05 CN disclosed
CN-1802342-A Improvements in or related to organic compounds GIVAUDAN SA (CH) 2006-07-12 CN disclosed
CN-1674862-A Perfume composition KAO CORP (JP) 2005-09-28 CN disclosed
CN-1531924-A Use of isovaleric acid derivatives CNS inhibitors in preparing medicine for curing headache NPSҩ�����޹�˾ 2004-09-29 CN disclosed
CN-1152677-C Treatment of spasticity and convulsions with isovaleric acid derivatives CNS inhibitors NPSҩ�����޹�˾ 2004-06-09 CN disclosed
US-6667285-B1 Branched-chain carboxylic acid monoalkyl ester with outstanding hydrolytic stability NEW JAPAN CHEMICAL CO., LTD. (JP) 2003-12-23 US disclosed
EP-1225213-A1 LUBRICATING OIL FOR REFRIGERATOR, HYDRAULIC FLUID COMPOSITION FOR REFRIGERATOR AND METHOD FOR LUBRICATION OF REFRIGERATOR NEW JAPAN CHEMICAL CO.,LTD. (JP) 2002-07-24 EP disclosed
CN-1235541-A Treatment of spasticity, convulsions with isovaleric acid derivatives CNS inhibitors NPS PHARMA INC (US) 1999-11-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160376234-A1 COLORING CURABLE RESIN COMPOSITION, CURED FILM, COLOR FILTER, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, IMAGE DISPLAY DEVICE, COMPOUND, AND CATION O60361, WDR12, SEM1 ALDH1A1 2079/4885ATM 1862/4885HCAR2 1636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.